NVDA vs SNPS

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.

Synopsys (SNPS) trades at a premium valuation with strong gross margins and solid long-term revenue growth, but faces significant near-term headwinds reflected in sharply declining earnings and negative price momentum. Despite a bullish analyst target price of $556.40 implying 43% upside, recent quarters have shown deteriorating profitability, with YoY EPS down 56.3% and a -44.3% earnings surprise in Q3 2025. The company maintains a healthy balance sheet with a Debt/Equity of 0.55 and strong liquidity, yet insider selling worth $29.76M over the past six months raises caution. Relative to peers like SNOW and ADI, SNPS exhibits better margins and cash flow discipline but lags in earnings growth and market sentiment, trading 40% below its 52-week high amid broader semiconductor cyclicality concerns.